190
Participants
Start Date
May 31, 2004
Primary Completion Date
September 30, 2005
Study Completion Date
January 31, 2008
Transcend II Model 8848
"All subjects will be implanted with the IGS device and then randomized to on or off for 12 months. After 12 months all subjects will be turned on through 24 month follow up."
Contact Medtronic for specific site information, New York
Contact Medtronic for specific site information, Philadelphia
Contact Medtronic for specific site information, Washington D.C.
Contact Medtronic for specfici site information, Gainsville
Contact Medtronic for specific site information, Minneapolis
Contact Medtronic for specific site information, Chicago
Contact Medtronic for specific site information, St Louis
Contact Medtronic for specific site information, Boston
Lead Sponsor
MedtronicNeuro
INDUSTRY